Site-directed Enzyme Enhancement Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
20
NCT06732180
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 21, 2025
Completion: Nov 30, 2025
Loading map...